Published online before print November 22, 2004, doi: 10.1161/01.HYP.0000150160.41992.71
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2005;45:15.)
© 2005 American Heart Association, Inc.
Editorial Commentaries |
Role of Circulating S-Nitrosothiols in Control of Blood Pressure
From the Howard Hughes Medical Institute (M.W.F., J.S.S.), and Departments of Medicine (J.R.P., J.S.S.) and Biochemistry (J.S.S.), Duke University Medical Center, Durham, NC; and the Department of Chemistry and Biochemistry (D.J.S.), Montana State University, Bozeman, Mont.
Correspondence to Jonathan S. Stamler, MD, Department of Medicine, Box 2612, Duke University Medical Center, Durham, NC 27710. Email STAML001@mc.duke.edu
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
The biological effects of nitric oxide (NO) are in large part mediated by S-nitrosylation of peptides and proteins to produce bioactive S-nitrosothiols (SNOs).1–3 The observation of abnormal SNO levels in numerous pathophysiological states2 suggests that dysregulation of SNO homeostasis may contribute to disease pathogenesis. For example, the hypotension of human sepsis is accompanied by increases in circulating levels of vasodilatory SNOs.3 Although such altered SNO levels may simply mirror NO production (eg, induction of inducible NO synthase in sepsis), they may also reflect changes specific to SNO biosynthesis and metabolism. Indeed, mice lacking a SNO-metabolizing enzyme are profoundly hypotensive under anesthesia.3 Thus, blood pressure is evidently regulated by both synthesis and turnover of SNOs. In this issue of Hypertension, Gandley et al4 extend this paradigm by proposing that a defect in SNO turnover contributes to the hypertension of preeclampsia.
In the blood, S-nitrosoalbumin (SNO-albumin) and S-nitrosohemoglobin (SNO-Hb) constitute the major conduits for circulating NO bioactivity. Although both SNOs may influence blood pressure, they operate within distinct signaling circuits. SNO-Hb can be viewed as a principal regulator of SNO homeostasis, adaptively modulating NO chemistry to control NO bioactivity. SNO-Hb is formed by transfer of NO from heme-iron to Cysß93 thiol on T to R structural transition (oxygenation) of the hemoglobin tetramer.5 SNO-Hb associates with the red blood cell (RBC) membrane via an interaction with the cytoplasmic domain of anion-exchanger 1 protein (CDAE1, Band 3); on deoxygenation (R
T) transfer of the NO group from SNO-Hb to
This article has been cited by other articles:
 |
|
 |
|
  H. G. Bohlen, X. Zhou, J. L. Unthank, S. J. Miller, and R. Bills Transfer of nitric oxide by blood from upstream to downstream resistance vessels causes microvascular dilation Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1337 - H1346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Corti, A. J. Flammer, N. K. Hollenberg, and T. F. Luscher Cocoa and Cardiovascular Health Circulation, March 17, 2009; 119(10): 1433 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nahas Complementary and alternative medicine approaches to blood pressure reduction: An evidence-based review Can Fam Physician, November 1, 2008; 54(11): 1529 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Loke, J. M Hodgson, J. M Proudfoot, A. J McKinley, I. B Puddey, and K. D Croft Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men Am. J. Clinical Nutrition, October 1, 2008; 88(4): 1018 - 1025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhu, S. Li, Z. M. Marshall, and A. R. Whorton A cystine-cysteine shuttle mediated by xCT facilitates cellular responses to S-nitrosoalbumin Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1012 - C1020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Carver, B. Gaston, K. deRonde, and L. A. Palmer Akt-Mediated Activation of HIF-1 in Pulmonary Vascular Endothelial Cells by S-Nitrosoglutathione Am. J. Respir. Cell Mol. Biol., September 1, 2007; 37(3): 255 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Taubert, R. Roesen, C. Lehmann, N. Jung, and E. Schomig Effects of Low Habitual Cocoa Intake on Blood Pressure and Bioactive Nitric Oxide: A Randomized Controlled Trial JAMA, July 4, 2007; 298(1): 49 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Li and A. R. Whorton Functional characterization of two S-nitroso-L-cysteine transporters, which mediate movement of NO equivalents into vascular cells Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1263 - C1271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hausladen, R. Rafikov, M. Angelo, D. J. Singel, E. Nudler, and J. S. Stamler Assessment of nitric oxide signals by triiodide chemiluminescence PNAS, February 13, 2007; 104(7): 2157 - 2162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-M. Zhang, C. St. Croix, R. Cao, K. Wasserloos, S. C. Watkins, T. Stevens, S. Li, V. Tyurin, V. E. Kagan, and B. R. Pitt Cell-surface protein disulfide isomerase is required for transnitrosation of metallothionein by s-nitroso-albumin in intact rat pulmonary vascular endothelial cells. Experimental Biology and Medicine, October 1, 2006; 231(9): 1507 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Heiss, T. Lauer, A. Dejam, P. Kleinbongard, S. Hamada, T. Rassaf, S. Matern, M. Feelisch, and M. Kelm Plasma Nitroso Compounds Are Decreased in Patients With Endothelial Dysfunction J. Am. Coll. Cardiol., February 7, 2006; 47(3): 573 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Orie, P. Vallance, D. P. Jones, and K. P. Moore S-nitroso-albumin carries a thiol-labile pool of nitric oxide, which causes venodilation in the rat Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H916 - H923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Rogers, A. Khalatbari, P. W. Gapper, M. P. Frenneaux, and P. E. James Detection of Human Red Blood Cell-bound Nitric Oxide J. Biol. Chem., July 22, 2005; 280(29): 26720 - 26728. [Abstract] [Full Text] [PDF]
|
|